Characteristics, Treatments and 1-Year Prognosis of Hospitalized and Ambulatory Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the European Society of Cardiology Heart Failure Long-Term Registry
Marco Canepa(Ospedale Policlinico San Martino), Luigi Tavazzi(Maria Cecilia Hospital), Andrew J.S. Coats(The Heart Research Institute), Mitja Lainščak, Pier Luigi Temporelli(Fondazione Salvatore Maugeri), Noémi Nyolczas, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Carla Fernández‐Vivancos(Hospital Universitario Virgen Macarena), Massimo Piepoli(University of Milan), Aldo P. Maggioni(Health Care Foundation), Roberto Ferrari(University of Ferrara), Cécile Laroche(European Society of Cardiology), Ewa Straburzyńska‐Migaj(Poznan University of Medical Sciences), José Manuel García Pinilla(Hospital Clínico Universitario Virgen de la Victoria), Jarosław Dróżdż(Copenhagen University Hospital)
Cited by 114
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k